Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein

Cancer Prevention Research

Volumn 8, Issue 9, 2015, Pages 873-878

  McRobbie, Hayden ^a   Phillips, Anna ^a   Goniewicz, Maciej L ^b   Smith, Katie Myers ^a   Knight West, Oliver ^c   Przulj, Dunja ^a   Hajek, Peter ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; CARBON MONOXIDE; CARBONYL DERIVATIVE; CREATININE; DRUG METABOLITE; GLYCOL; NICOTINE; S (3 HYDROXYPROPROPYL)MERCAPTURIC ACID; UNCLASSIFIED DRUG; ACETYLCYSTEINE; AEROSOL; BIOLOGICAL MARKER; COTININE; S-(3-HYDROXYPROPYL)CYSTEINE N-ACETATE; SMOKE;

ADULT; AEROSOL; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRY NOSE; DRY THROAT; ELECTRONIC CIGARETTE; FEMALE; FLATULENCE; HEADACHE; HUMAN; MALE; MEASUREMENT ACCURACY; MEDICAL DEVICE COMPLICATION; MOUTH DISCOMFORT; NAUSEA; PRIORITY JOURNAL; RISK REDUCTION; SMOKING; SMOKING CESSATION; THROAT IRRITATION; URINE LEVEL; VERTIGO; VOMITING; XEROSTOMIA; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BREATH ANALYSIS; COHORT ANALYSIS; MIDDLE AGED; SMOKE; URINE;

ACETYLCYSTEINE; ACROLEIN; ADULT; AEROSOLS; BIOMARKERS; BREATH TESTS; CARBON MONOXIDE; COHORT STUDIES; COTININE; ELECTRONIC CIGARETTES; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKE; SMOKING; SMOKING CESSATION;

EID: 84941772316     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0058     Document Type: Article

References (33)

1. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humansagents [Internet]. Geneva, Switzerland: International Agency for Research on Cancer; 2012. Available from: http://monographs.iarc.fr/ENG/Classification/index.php
2. Kosmider L, Sobczak A, Fik M, Knysak J, Zaciera M, Kurek J, et al. Carbonyl compounds in electronic cigarette vapors-effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014;16:1319-26.
3. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133-9.
4. Ohta K, Uchiyama S, Naba Y, Nakagome H, Kunugita N. Determination of carbonyl compounds generated from the electronic cigarette using coupled silica cartridgesimpregnated with hydroquinone and 2, 4-Dinitrophenylhydrazine. Bunseki Kagaku 2011;60:791-7.
5. Bekki K, Uchiyama S, Ohta K, Inaba Y, Nakagome H, Kunugita N. Carbonyl compounds generated from electronic cigarettes. Int J Environ Res Public Health 2014;11:11192-200.
6. National Cancer Institute. Smoking and tobacco control monograph 9: Cigars: health effects and trends [Internet]. Bethesda, MD: National Cancer Institute; 1998. Available from: http://cancercontrol.cancer.gov/brp/tcrb/monographs/9/m9-complete. PDF.
7. Bein K, Leikauf GD. Acrolein - a pulmonary hazard. Mol Nutr Food Res 2011;55:1342-60.
8. Yuan J-M, Gao Y-T, Wang R, Chen M, Carmella SG, Hecht SS. Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis 2012;33:804-9.
9. Stevens JF, Maier CS. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res 2008;52:7-25.
10. Moretto N, Volpi G, Pastore F, Facchinetti F. Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease. AnnNY Acad Sci 2012;1259:39-46.
11. Shi R, Rickett T, Sun W. Acrolein-mediated injury in nervous system trauma and diseases. Mol Nutr Food Res 2011;55:1320-31.
12. Park YS, Taniguchi N. Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis. Ann N Y Acad Sci 2008;1126:185-9.
13. De Jarnett N, Conklin DJ, Riggs DW, Myers JA, O'Toole TE, Hamzeh I, et al. Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc 2014;3: pii: e000934.
14. McEwen A, Hajek P, McRobbie H, West R. Manual of smoking cessation: a guide for counsellors and practitioners. Oxford, UK: John Wiley & Sons; 2008.
15. Hajek P, Goniewicz ML, Phillips A, Myers Smith K, West O, McRobbie H. Nicotine intake from electronic cigarettes on initial use and after four weeks of regular use. Nicotine Tob ResOff J Soc Res Nicotine Tob 2015;17:175-9.
16. Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 2014;109:500-7.
17. Green Smoke. Cartridge information: What's inside the cartridges? [Internet]. [cited 2014 May 12]. Available from: http://www.greensmoke.co.uk/ecig-faq
18. West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology (Berl) 2004;177:195-9.
19. ABS Laboratories. [cited 2015 Apr. 15]. Available from: http://www.abslabs.co.uk
20. Center for Drug Evaluation and Research. Guidance for industry - bioanalytical method validation [Internet]. Rockville, MD: Center for Drug Evaluation and Research; Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf
21. European Medicines Agency. Guideline on bioanalytical method validation [Internet]. London, UK: EMEA; 2011. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2011/08/WC500109686.pdf
22. International Conference on Harmonization. Guideline on good clinical practice [Internet]. Geneva; 1997. Available from: http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/good-clinical-practice.html
23. Goniewicz ML, Knysak J, Kosmider L, Zaciera M, Kurek J, Sobczak A, et al. Assessment of electronic cigarettes as a source of exposure to acrolein. International Meeting of the Society for Research on Nicotine and Tobacco. Boston, MA; March 2013.
24. Scherer G, Engl J, Urban M, Gilch G, Janket D, Riedel K. Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul Toxicol Pharmacol RTP 2007;47:171-83.
25. Hecht SS, Carmella SG, Kotandeniya D, Pillsbury ME, Chen M, Ransom BWS, et al. evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res Off J Soc Res Nicotine Tob 2015;17:704-9.
26. Carmella SG, Chen M, Han S, Briggs A, Jensen J, Hatsukami DK, et al. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol 2009;22:734-41.
27. Health and Social Care Information Centre. Statistics onNHS Stop Smoking Services, England - April 2012 to March 2013 [Internet]; 2013 [cited 2014 May 9]. Available from: http://www.hscic.gov. uk/catalogue/PUB12228
28. McRobbie H, Przulj D, Myers-Smith K, Cornwall D, Hajek P. Complementing current NHS Stop Smoking Service treatment for smokers with behavioural replacement: the role of de-nicotinised cigarettes. Boston: SRNT; 2013.
29. Beard E, Bruguera C, Brown J, McNeill A, West R. Was the expansion of the marketing license for nicotine replacement therapy in the United kingdom to include smoking reduction associatedwith changes in use and incidence of quit attempts? Nicotine Tob Res Off J Soc Res Nicotine Tob 2013;15:1777-81.
30. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health Electron Resour 2013;10:446-61.
31. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011;11:786.
32. Farsalinos KE, Vassilis V, Konstantinos P. E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions. Addiction 2015;110:1352-1356.
33. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine & Tobacco Research 2012;14:75-78.